Case series: successful salvage from refractory cardiogenic shock caused by COVID-19-associated myocardial injury with temporary ventricular assist devices
Open Access
- 29 June 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (7) , ytae308
Abstract
Background: Coronavirus disease 2019 (COVID-19) is predominantly known to cause respiratory injury; however, the present case series highlights four instances in which the infection resulted in significant cardiac complications. Among such cases, some represent severe cardiogenic shock, which necessitates the immediate introduction of mechanical circulatory support (MCS) for salvage. Case summary: This case series involved patients with COVID-19-associated myocardial injury leading to fulminant cardiogenic shock. These patients required immediate implementation of peripheral MCS, followed by an instant upgrade to a central MCS system due to anatomical limitations and severe biventricular dysfunction. Central MCS provided effective ventricular unloading, resulting in a significant and prompt improvement in ventricular function. The treatment timeline showed rapid deterioration followed by remarkable recovery within 2 weeks of MCS initiation, demonstrating the effectiveness of aggressive and tailored MCS strategies in managing severe COVID-19-related cardiac complications. Discussion: This study provides significant insights into the cardiovascular implications of COVID-19, particularly in the context of severe myocardial injury that leads to cardiogenic shock. The report underscores the importance of early recognition and intervention in such cases, focusing on the use of MCS as a life-saving modality. The findings also revealed unique pathological features of COVID-19-associated myocardial injury, including macrophage-predominant infiltration and microthrombosis, which are distinct from the features of conventional myocarditis. These findings highlight the need for further research on the pathophysiology of COVID-19-related cardiac injuries and the development of targeted therapeutic strategies.Keywords
This publication has 14 references indexed in Scilit:
- Fulminant Delta COVID-19 myocarditis: a case report of fatal primary cardiac dysfunctionEuropean Heart Journal - Case Reports, 2022
- Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute MyocarditisCirculation, 2022
- Coronavirus disease (COVID-19) associated delayed-onset fulminant myocarditis in patient with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionJournal of Infection and Chemotherapy, 2021
- COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanismCardiovascular Pathology, 2021
- Successful Heart Transplantation for COVID-19-Associated Post-Infectious Fulminant MyocarditisESC Heart Failure, 2021
- Microthrombi as a Major Cause of Cardiac Injury in COVID-19Circulation, 2021
- Fulminant myocarditis in a COVID-19 positive patient treated with mechanical circulatory support – a case reportEuropean Heart Journal - Case Reports, 2020
- Ventricular Assist Device for a Coronavirus Disease 2019-Affected HeartESC Heart Failure, 2020
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesEuropean Heart Journal, 2013
- A novel real‐time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnosesJournal of Medical Virology, 2010